The pioneering healthcare company, XRHealth, announced the integration of Tobii’s medical-grade eye-tracking tech for their VR platform used for virtual therapy sessions. The new feature will enable clinicians to assist patients with neurological conditions, such as Parkinson’s Disease, Multiple Sclerosis, and Autism.
Tobii eye-tracking finds its way to the Pico Neo 3 Pro Eye headsets, powered by the Qualcomm® Snapdragon™ XR2 Platform. It will aid clinicians in measuring and diagnosing neurological conditions to assist patients better. They can use the tech to treat symptoms by increasing attention span, improving eye contact, and more.
For instance, during therapy sessions, they could use it to measure the patient’s pupil as a biomarker for stress and anxiety. Moreover, the clinicians will be able to collect a lot more data using the new eye-tracking capabilities and evaluate a patient’s progress over the treatment more comprehensively.
“We are equipping our patients with the latest virtual reality technology so that they have access to the best healthcare experience available today,” said Eran Orr, Founder and Chief Executive Officer at XRHealth. “We are excited to partner with Tobii – the leader in eye-tracking – which will significantly improve patient treatment with accurate neurological measurements to provide markers for success.”
XRHealth’s VR platform provides data and insights to patients and clinicians in real-time to track and measure the methods adopted during therapy and make necessary changes as they progress.
“At Tobii, our mission is to create a better future for everyone through innovative technology,” said Johan Hellqvist, VP of XR at Tobii. “XRHealth’s eye-tracking integration to their VR platform proves once again that our technology positively impacts people’s health and lives. As a company, we are committed to catalyzing the commercialization of healthcare innovations and working with partners to address challenges.”
Follow us on LinkedIn
Read other Articles